BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10351446)

  • 1. Health care compliance plans.
    Becker S
    Health Care Law Mon; 1999 Mar; ():14-27. PubMed ID: 10351446
    [No Abstract]   [Full Text] [Related]  

  • 2. Crisis prevention and damage control: managing whistle-blowers.
    Queen D
    MLO Med Lab Obs; 1999 Aug; 31(8):16-21. PubMed ID: 10558023
    [No Abstract]   [Full Text] [Related]  

  • 3. The paper monster. Corporate compliance and the board.
    Hinrichsen CA; Capobianco C; Diamond M
    Trustee; 2001 Feb; 54(2):12-6, 1. PubMed ID: 11262926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMA urges physician office compliance plans: what should you do now?
    Schwartz JB; Snider JG
    Health Care Law Mon; 1998 Nov; ():12-5. PubMed ID: 10346225
    [No Abstract]   [Full Text] [Related]  

  • 5. A trustee's guide to compliance. Questions you need to ask managers about meeting the letter of the law.
    Morris L; Roosevelt J
    Mod Healthc; 2003 Jun; 33(26):20. PubMed ID: 12858639
    [No Abstract]   [Full Text] [Related]  

  • 6. DMEPOS (Durable Medical Equipment, Prosthetics, Orthotics and Supply) model compliance program: does the OIG have it right?
    Parver C; O'Connor B
    Caring; 1999 Jun; 18(6):20-3. PubMed ID: 10538888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shift seen in anti-fraud compliance efforts.
    Saunders B
    Mod Healthc; 1999 Nov; 29(48):26. PubMed ID: 10662200
    [No Abstract]   [Full Text] [Related]  

  • 8. Using the OIG model compliance programs to fight fraud.
    Lovitky JA; Ahern J
    Healthc Financ Manage; 2002 Mar; 56(3):64-8. PubMed ID: 11899726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corporate compliance plans: building the bridge to a well-managed future.
    Bruder P
    Hosp Top; 1998; 76(1):32-4. PubMed ID: 10181331
    [No Abstract]   [Full Text] [Related]  

  • 10. An audit a day keeps the agency at bay: OIG's evolving view of hospital compliance programs (part 2).
    Siegel S
    Health Care Law Mon; 2004 Sep; ():3-9. PubMed ID: 15484833
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of internal investigations--an overview primer.
    Becker S; Werling K
    Health Care Law Mon; 2003 Aug; ():3-8. PubMed ID: 13677061
    [No Abstract]   [Full Text] [Related]  

  • 12. Creating a corporate compliance program. Steps to a program that reinforces mission and protects the organization.
    Gunn JF; Goldfarb ER; Showalter JS
    Health Prog; 1998; 79(3):60-3. PubMed ID: 10180027
    [No Abstract]   [Full Text] [Related]  

  • 13. Compliance: Part I.
    Grabowski D
    NAHAM Manage J; 1998; 24(6):8. PubMed ID: 10387360
    [No Abstract]   [Full Text] [Related]  

  • 14. Managed care under siege: how an effective compliance program can protect your company.
    Stratton KM; Nahra MH
    Manag Care Q; 1996; 4(1):80-5. PubMed ID: 10154069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective health care corporate compliance.
    Saum TB; Byassee J
    Physician Exec; 2000; 26(3):56-9. PubMed ID: 10947465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing compliance programs that foster ethical behavior.
    Lovitky JA; Ahern J
    Healthc Financ Manage; 1999 Mar; 53(3):38, 40-2. PubMed ID: 10351054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis and recommendations on the draft OIG compliance program for individual and small group physician practices.
    Norris S
    Health Care Law Mon; 2000 Jul; ():3-15. PubMed ID: 11066642
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing board relationships in tough times.
    Commins K; Render J
    Mich Health Hosp; 2003; 39(4):56-7. PubMed ID: 12886663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is a board's liability for not adopting a compliance program?
    Robinson F; Pauzé CC
    Healthc Financ Manage; 1997 Sep; 51(9):64-6. PubMed ID: 10170320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Codes of ethics in the wake of Sarbanes-Oxley.
    Maltz A
    Trustee; 2003; 56(10):31-2. PubMed ID: 14650273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.